Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory.

Publisher: Blackwell Science, Inc Country of Publication: United States NLM ID: 101130835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-2500 (Electronic) Linking ISSN: 15307085 NLM ISO Abbreviation: Pain Pract Subsets: MEDLINE

Original Publication: Malden, Mass. : Blackwell Science, Inc., c2001-

Central Nervous System Sensitization* ; Patient Reported Outcome Measures* ; Surveys and Questionnaires*; Catastrophization/*diagnosis ; Psychometrics/*instrumentation; Adult ; Chronic Pain/psychology ; Female ; Humans ; Language ; Male ; Middle Aged ; Serbia ; Translating

Objectives: The goal of the present study was to explore additional evidence of validity of the Serbian version of the Central Sensitization Inventory (CSI), a patient-reported outcome measure of symptoms that have been found to be associated with central sensitization (CS). The CSI has been found to be psychometrically sound, and has demonstrated evidence of convergent and discriminant validity in numerous published studies and in multiple languages.
Methods: CSI data were collected from 399 patients with chronic pain who had various diagnoses and from 146 pain-free controls. In addition, the patient sample completed a battery of validated patient-reported outcome measures of sleep problems, cognitive problems, pain catastrophizing, pain-related fear-avoidance, decreased quality of life, and decreased perception of social support. Six patient subgroups were formed, with presumably different levels of CS (including those with fibromyalgia, multiple pain sites, and localized pain sites).
Results: Significant differences were found in total CSI scores among the controls and patient subgroups. Those with fibromyalgia and multiple pathologies scored highest and the control subjects scored lowest. Other patient-reported CS-related symptom dimensions were significantly correlated with total CSI scores. When the patients were divided into CSI severity subgroups (from subclinical to extreme), the severity of these other symptom dimensions increased with the severity of CSI scores.
Conclusions: The current study successfully demonstrated additional evidence of the convergent and discriminant validity of the Serbian version of the CSI.
(© 2020 World Institute of Pain.)

Mayer TG, Neblett R, Cohen H, et al. The development and psychometric validation of the Central Sensitization Inventory. Pain Pract. 2012;12:276-285.
Neblett R, Hartzell MM, Mayer TG, Cohen H, Gatchel RJ. Establishing clinically relevant severity levels for the Central Sensitization Inventory. Pain Pract. 2017;17:166-175.
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2-S15.
Yunus MB. A unified concept for fibromyalgia and other similar maladies. J Ind Rheumatol Assoc. 2000;8:27-33.
Neblett R. The Central Sensitization Inventory: a user’s manual. J Appl Behav Res. 2018;23:e12123.
Bilika P, Neblett R, Georgoudis G, et al. Cross-cultural adaptation and psychometric properties of the Greek version of the Central Sensitization Inventory. Pain Pract. 2020;20:188-196.
Andias R, Silva AG. Cross-cultural adaptation and psychometric properties of the European Portuguese version of the Central Sensitization Inventory in adolescents with musculoskeletal chronic pain. Pain Pract. 2020. https://doi.org/10.1111/papr.12875.
Scerbo T, Colasurdo J, Dunn S, Unger J, Nijs J, Cook C. Measurement properties of the Central Sensitization Inventory: a systematic review. Pain Pract. 2018;18:544-554.
Knezevic A, Neblett R, Jeremic-Knezevic M, et al. Cross-cultural adaptation and psychometric validation of the Serbian version of the Central Sensitization Inventory. Pain Pract. 2018;18:463-472.
Curatolo M, Muller M, Ashraf A, et al. Pain hypersensitivity and spinal nociceptive hypersensitivity in chronic pain: prevalence and associated factors. Pain 2015;156:2373-2382.
Neblett R, Mayer TG, Williams MJ, et al. The fear-avoidance components scale (FACS): responsiveness to functional restoration treatment in a chronic musculoskeletal pain disorder (CMPD) population. Clin J Pain. 2017;33:1088-1099.
Neblett R, Mayer TG, Hartzell MM, Williams MJ, Gatchel RJ. The Fear-Avoidance Components Scale (FACS): development and psychometric evaluation of a new measure of pain-related fear avoidance. Pain Pract. 2016;16:435-450.
Knezevic A, Neblett R, Gatchel RJ, et al. Psychometric validation of the Serbian version of the Fear Avoidance Component Scale (FACS). PLoS ONE 2018;13:e0204311.
Sullivan MJL, Bischop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assessment. 1995;7:524-532.
Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25:2940-2953; discussion 2952.
Baker DJ, Pynsent PB, Fairbank JC. The Oswestry Disability revisited. In: Roland-Jenner JR, ed. Back Pain: New Approaches to Rehabilitation and Education. Manchester, U.K.: Manchester University Press; 1989:174-186.
Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry Low Back Pain Disability Questionnaire. Physiotherapy. 1980;66:271-273.
Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess. 1990;55:610-617.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988;52:30-41.
Maruish ME. User’s Manual for the SF-36v2 Health Survey. 3rd ed. Lincoln, RI: QualityMetric Incorporated; 2011.
Stewart AL, Ware JE. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6:41-44.
Hays RD, Stewart AL. Measuring functioning and well-being: the Medical Outcomes Study approach. In: Stewart AL, Ware JE, eds. Sleep Measures. Durham, NC: Duke University Press; 1992:235-259.
Spritzer KL, Hays RD. MOS Sleep Scale: A Manual for Use and Scoring (Version 1.0). Los Angeles, CA: RAND Corporation; 2003.
Champely S, Ekstrom C, Dalgaard P, et al.Package ‘pwr’. R package version, 1.2-2; 2018. https://cran.r-project.org/package=pwr (accessed September 18, 2019).
JASP Team. JASP (Version 0.12.2); 2020. https://jasp-stats.org/ (accessed January 09, 2020).
Cohen JW. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
Revelle W. psych: Procedures for Personality and Psychological Research. 1.8.12. Evanston, IL: Northwestern University; 2018.
Ogle DH, Wheeler P, Dinno A. FSA: Fisheries Stock Analysis. R package 0.8.22; 2018. https://github.com/droglenc/FSA (accessed February 25, 2020).
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019.
Harper DE, Schrepf A, Clauw DJ. Pain mechanisms and centralized pain in temporomandibular disorders. J Dent Res. 2016;95:1102-1108.
Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015;90:680-692.
Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36:339-356.
Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10:777-791.
Banic B, Petersen-Felix S, Andersen OK, et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 2004;107:7-15.
Smart KM, Blake C, Staines A, Doody C. Clinical indicators of 'nociceptive', 'peripheral neuropathic' and 'central' mechanisms of musculoskeletal pain. A Delphi survey of expert clinicians. Man Ther. 2010;15:80-87.
Andersson HI, Ejlertsson G, Leden I, Rosenberg C. Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol. 1996;25:146-154.
Mayer TG, Towns BL, Neblett R, Theodore BR, Gatchel RJ. Chronic widespread pain in patients with occupational spinal disorders: prevalence, psychiatric comorbidity, and association with outcomes. Spine (Phila Pa 1976). 2008;33:1889-1897.
Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis. 2004;63:723-729.
Giesbrecht RJ, Battie MC. A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther. 2005;85:1085-1092.
Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 2004;50:613-623.
Bid DD, Soni NC, Rathod PV. Central sensitization in chronic low back pain: a narrative review. Natl J Integr Res Med. 2016;7:114-123.
Sanzarello I, Merlini L, Rosa MA, et al. Central sensitization in chronic low back pain: a narrative review. J Back Musculoskelet Rehabil. 2016;29:625-633.
Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med. 2010;42:884-890.
Malfliet A, Kregel J, Cagnie B, et al. Lack of evidence for central sensitization in idiopathic, non-traumatic neck pain: a systematic review. Pain Physician. 2015;18:223-236.
Marcuzzi A, Dean CM, Wrigley PJ, Hush JM. Early changes in somatosensory function in spinal pain: a systematic review and meta-analysis. Pain 2015;156:203-214.
Sjors A, Larsson B, Persson AL, Gerdle B. An increased response to experimental muscle pain is related to psychological status in women with chronic non-traumatic neck-shoulder pain. BMC Musculoskelet Disord. 2011;12:230.
Kindler LL, Jones KD, Perrin N, Bennett RM. Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain. 2010;11:1320-1328.
Kregel J, Vuijk PJ, Descheemaeker F, et al. The Dutch Central Sensitization Inventory (CSI): factor analysis, discriminative power, and test-retest reliability. Clin J Pain. 2016;32:624-630.
Pitance L, Piraux E, Lannoy B, et al. Cross cultural adaptation, reliability and validity of the French version of the Central Sensitization Inventory. Man Ther. 2016;25:e57-e169.
Caumo W, Antunes LC, Elkfury JL, et al. The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor. J Pain Res. 2017;10:2109-2122.
Neblett R, Cohen H, Choi Y, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14:438-445.
Neblett R, Hartzell MM, Williams M, Bevers KR, Mayer TG, Gatchel RJ. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program. Spine J. 2017;17:1819-1829.
Kregel J, Schumacher C, Dolphens M, et al. Convergent validity of the Dutch Central Sensitization Inventory: associations with psychophysical pain measures, quality of life, disability, and pain cognitions in patients with chronic spinal pain. Pain Pract. 2018;18:777-787.
Tanaka K, Nishigami T, Mibu A, et al. Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders. PLoS ONE 2017;12:e0188719.
Roussel NA, Nijs J, Meeus M, Mylius V, Fayt C, Oostendorp R. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin J Pain. 2013;29:625-638.
Neugebauer V, Galhardo V, Maione S, Mackey SC. Forebrain pain mechanisms. Brain Res Rev. 2009;60:226-242.
Huysmans E, Ickmans K, Van Dyck D, et al. Association between symptoms of central sensitization and cognitive behavioral factors in people with chronic nonspecific low back pain: a cross-sectional study. J Manipulative Physiol Ther. 2018;41:92-101.
Coppieters I, Ickmans K, Cagnie B, et al. Cognitive performance is related to central sensitization and health-related quality of life in patients with chronic whiplash-associated disorders and fibromyalgia. Pain Physician. 2015;18:E389-E401.
Veldhuijzen DS, Sondaal SF, Oosterman JM. Intact cognitive inhibition in patients with fibromyalgia but evidence of declined processing speed. J Pain. 2012;13:507-515.
Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol. 2009;27:S67-S74.
Wallin MK, Raak RI. Quality of life in subgroups of individuals with whiplash-associated disorders. Eur J Pain. 2008;12:842-849.
Engstrom M, Hagen K, Bjork MH, et al. Sleep quality, arousal and pain thresholds in migraineurs: a blinded controlled polysomnographic study. J Headache Pain. 2013;14:12.
Odegard SS, Sand T, Engstrom M, Zwart JA, Hagen K. The impact of headache and chronic musculoskeletal complaints on the risk of insomnia: longitudinal data from the Nord-Trondelag health study. J Headache Pain. 2013;14:24.
Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004;8:119-132.
LeBlanc M, Merette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009;32:1027-1037.
Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14:1539-1552.
de Tommaso M, Delussi M, Vecchio E, Sciruicchio V, Invitto S, Livrea P. Sleep features and central sensitization symptoms in primary headache patients. J Headache Pain. 2014;15:64.
Haviland MG, Morton KR, Oda K, Fraser GE. Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis. Psychiatry Res. 2010;177:335-341.
Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009;122:S22-30.
Harkness EF, Macfarlane GJ, Nahit E, Silman AJ, McBeth J. Mechanical injury and psychosocial factors in the work place predict the onset of widespread body pain: a two-year prospective study among cohorts of newly employed workers. Arthritis Rheum. 2004;50:1655-1664.
Lopez-Martinez AE, Esteve-Zarazaga R, Ramirez-Maestre C. Perceived social support and coping responses are independent variables explaining pain adjustment among chronic pain patients. J Pain. 2008;9:373-379.
Neblett R, Hartzell MM, Cohen H, et al. Ability of the Central Sensitization Inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain. 2015;31:323-332.
Turk DC, Okifuji A, Sinclair JD, Starz TW. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res. 1998;11:186-195.
Anagnostis C, Gatchel RJ, Mayer TG. The Pain Disability Questionnaire: a new psychometrically sound measure for chronic musculoskeletal disorders. Spine (Phila Pa 1976). 2004;29:2290-2302; discussion 2303.
Wise TN, Mann LS. Utilization of pain medications in hospitalized psychiatric patients. Gen Hosp Psychiatry. 1996;18:422-425.
Curatolo M. Diagnosis of altered central pain processing. Spine (Phila Pa 1976). 2011;36:S200-S204.
Schiffman EL, Ohrbach R, Truelove EL, et al. The research diagnostic criteria for temporomandibular disorders. V: Methods used to establish and validate revised axis I diagnostic algorithms. J Orofac Pain. 2010;24:63-78.
Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6:301-355.

Keywords: central sensitization; central sensitization inventory; chronic pain; fibromyalgia

Date Created: 20200415 Date Completed: 20201221 Latest Revision: 20201221

20221213

10.1111/papr.12900

32285543